DD254939A5 - Verfahren zur herstellung von 7-isoproxy-isoflavon mit cyclodextrinen - Google Patents
Verfahren zur herstellung von 7-isoproxy-isoflavon mit cyclodextrinen Download PDFInfo
- Publication number
- DD254939A5 DD254939A5 DD86294265A DD29426586A DD254939A5 DD 254939 A5 DD254939 A5 DD 254939A5 DD 86294265 A DD86294265 A DD 86294265A DD 29426586 A DD29426586 A DD 29426586A DD 254939 A5 DD254939 A5 DD 254939A5
- Authority
- DD
- German Democratic Republic
- Prior art keywords
- cyclodextrin
- ipriflavone
- isoflavone
- isopropoxy
- solubility
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
- A61K31/37—Coumarins, e.g. psoralen
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
- A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
- C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
- C08B37/0012—Cyclodextrin [CD], e.g. cycle with 6 units (alpha), with 7 units (beta) and with 8 units (gamma), large-ring cyclodextrin or cycloamylose with 9 units or more; Derivatives thereof
- C08B37/0015—Inclusion compounds, i.e. host-guest compounds, e.g. polyrotaxanes
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nanotechnology (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Physical Education & Sports Medicine (AREA)
- General Engineering & Computer Science (AREA)
- Crystallography & Structural Chemistry (AREA)
- Biochemistry (AREA)
- Materials Engineering (AREA)
- Polymers & Plastics (AREA)
- Biophysics (AREA)
- Biotechnology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Medical Informatics (AREA)
- Rheumatology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyrane Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Absorbent Articles And Supports Therefor (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HU853415A HU199444B (en) | 1985-09-10 | 1985-09-10 | Process for producing 7-isopropoxy-isoflavone-cyclodextrene inclusion complex and pharmaceutical compositions therefrom |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DD254939A5 true DD254939A5 (de) | 1988-03-16 |
Family
ID=10963942
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DD86294265A DD254939A5 (de) | 1985-09-10 | 1986-09-09 | Verfahren zur herstellung von 7-isoproxy-isoflavon mit cyclodextrinen |
Country Status (16)
| Country | Link |
|---|---|
| US (2) | US4826963A (fi) |
| EP (1) | EP0214647B1 (fi) |
| JP (1) | JPH0688993B2 (fi) |
| KR (1) | KR900000542B1 (fi) |
| CN (1) | CN1006889B (fi) |
| AT (1) | ATE87319T1 (fi) |
| CA (1) | CA1288424C (fi) |
| CS (1) | CS653586A3 (fi) |
| DD (1) | DD254939A5 (fi) |
| DE (1) | DE3688114D1 (fi) |
| FI (1) | FI86958C (fi) |
| HU (1) | HU199444B (fi) |
| PL (1) | PL261349A1 (fi) |
| RU (1) | RU2022970C1 (fi) |
| SU (1) | SU1757472A3 (fi) |
| UA (1) | UA19813A (fi) |
Families Citing this family (39)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5221695A (en) * | 1987-12-22 | 1993-06-22 | Glaxo Group Limited | Aqueous formulation containing a piperidinylcyclopentylheptenoic acid derivative and beta-cyclodextrin |
| SI8810082A8 (en) * | 1988-01-18 | 1995-12-31 | Lek Tovarna Farmacevtskih | Process for preparing new inclusion complex of nicardipine or its hydrochloride with beta-cyclodextrine |
| DE3809808A1 (de) * | 1988-03-23 | 1989-10-05 | Hexal Pharma Gmbh & Co Kg | Feste, insbesondere festorale und rektale, etofenamat enthaltende arzneimittel |
| MY106598A (en) * | 1988-08-31 | 1995-06-30 | Australian Commercial Res & Development Ltd | Compositions and methods for drug delivery and chromatography. |
| JPH02142709A (ja) * | 1988-11-24 | 1990-05-31 | Kurita Water Ind Ltd | 有害生物防除剤 |
| WO1991004026A1 (en) * | 1989-09-14 | 1991-04-04 | Australian Commercial Research & Development Limited | Drug delivery compositions |
| IT1241673B (it) * | 1989-10-09 | 1994-01-27 | Istituto Biochimico Italiano | Complessi di inclusione di silibinina con ciclodestrina, loro preparazione e composizioni farmaceutiche che li contengono. |
| WO1991013100A1 (en) * | 1990-03-02 | 1991-09-05 | Australian Commercial Research & Development Limited | Cyclodextrin compositions and methods for pharmaceutical and industrial applications |
| IT1241079B (it) * | 1990-03-23 | 1993-12-29 | Chiesi Farma Spa | Composizioni farmaceutiche contenenti ipriflavone,procedimento per la loro preparazione e relativo impiego terapeutico |
| US5221735A (en) * | 1991-02-25 | 1993-06-22 | Hoffmann-La Roche Inc. | Cyclodextrin-polyene inclusion complexes |
| JPH06248193A (ja) * | 1993-02-25 | 1994-09-06 | Ensuiko Sugar Refining Co Ltd | クロセチン含有着色料 |
| HU212932B (en) * | 1993-08-02 | 1996-12-30 | Chinoin Gyogyszer Es Vegyeszet | Parmaceutical composition containing ipriflavone, hydroxyapatit and tricalciumphosphate for treating lack of bones and process for producing the composition |
| PE36795A1 (es) * | 1993-12-14 | 1995-11-06 | Lilly Co Eli | Complejo de inclusion en solucion acuosa de compuestos de benzotiofeno con ciclodextrinas solubles en agua, formulaciones farmaceuticas y procedimiento de obtencion |
| US5506211A (en) * | 1994-05-09 | 1996-04-09 | The Uab Research Foundation | Genistein for use in inhibiting osteroclasts |
| US6298558B1 (en) * | 1994-10-31 | 2001-10-09 | The Gillette Company | Skin engaging member |
| HUT73844A (en) * | 1994-11-11 | 1996-09-30 | Chinoin Gyogyszer Es Vegyeszet | New taxol complexes and pharmaceutical compositions containing them |
| WO1996040262A2 (en) * | 1995-06-07 | 1996-12-19 | The Procter & Gamble Company | Process for preparing encapsulated water soluble beta-carotene |
| US5847108A (en) * | 1996-03-21 | 1998-12-08 | Fujicco Co., Ltd. | Clathrate of isoflavone derivatives and edible composition comprising the same |
| ES2251212T3 (es) | 1998-03-06 | 2006-04-16 | Meiji Seika Kaisha, Ltd. | Agentes para prevenir/tratar la osteoporosis. |
| JP4006133B2 (ja) | 1999-05-17 | 2007-11-14 | 松谷化学工業株式会社 | 可溶性イソフラボン組成物及びその製造方法 |
| NZ520237A (en) | 1999-12-17 | 2004-05-28 | Mitsunori Ono | Water-soluble bean-based extracts |
| US6541062B2 (en) | 1999-12-17 | 2003-04-01 | Mitsunori Ono | Water-soluble soybean extracts |
| US7182972B2 (en) * | 1999-12-17 | 2007-02-27 | Quercegen Pharma, Llc | Water-soluble bean-based extracts |
| JP4585074B2 (ja) * | 2000-03-28 | 2010-11-24 | ライオン株式会社 | 薬剤組成物の製造方法 |
| CA2304906A1 (en) * | 2000-04-07 | 2001-10-07 | 1411198 Ontario Limited | 13-hode, a regulator of vascular biocompatibility and an inhibitor of cell hyperplasia |
| DE10211192A1 (de) * | 2002-03-14 | 2003-09-25 | Beiersdorf Ag | Isoflavanoide gegen Hautalterung und Akne |
| WO2004045541A2 (en) * | 2002-11-15 | 2004-06-03 | Cargill, Incorporated | Soluble isoflavone compositions |
| US7157446B2 (en) * | 2003-05-02 | 2007-01-02 | Bristol Myers Squibb Company | Complex of ras-farnesyltransferase inhibitor, a cyclodextrin, and ethanol |
| US6960300B2 (en) * | 2003-09-08 | 2005-11-01 | Sami Labs Limited | Process for preparing water soluble diterpenes and their applications |
| KR100847225B1 (ko) | 2003-10-24 | 2008-07-17 | (주)아모레퍼시픽 | 사이클로 덱스트린의 분자 인식 기능을 이용한이소플라본의 추출방법 |
| US20100055172A1 (en) * | 2006-11-03 | 2010-03-04 | Choi Yong Han | Encapsulated soy extracts and process for preparing same |
| JP4978209B2 (ja) * | 2007-01-22 | 2012-07-18 | 株式会社イヅツみそ | フリーズドライ味噌の製造方法 |
| KR100929920B1 (ko) * | 2007-09-05 | 2009-12-04 | 주식회사 마크로케어 | 사이클로덱스트린 및 이의 유도체에 소수성 생리활성성분이 포접된 포접체의 제조방법 및 이로써 제조된포접체의 용도 |
| EP2106786A1 (de) * | 2008-04-04 | 2009-10-07 | Roewer, Norbert, Univ.-Prof. Dr. med. | Pharmazeutische Zubereitung mit permethyliertem Cyclodextrin |
| US20110293537A1 (en) * | 2008-11-24 | 2011-12-01 | Giovanni Nicolao Berta | formulations with anti-neoplastic activity |
| CN101757640B (zh) * | 2009-06-09 | 2011-08-31 | 东华大学 | 一种鹰嘴豆异黄酮与环糊精包合物的制备 |
| DK2919791T3 (da) | 2012-11-15 | 2017-07-17 | Sapiotec Gmbh | Delphinidin-kompleks som antiflogistisk eller immunsuppressivt aktivt stof |
| KR20150107742A (ko) | 2012-12-11 | 2015-09-23 | 자피오텍 게엠베하 | 흑색종 세포를 퇴치하기 위한 델피니딘 |
| LT3565602T (lt) | 2017-01-09 | 2021-06-25 | SciPharm S.à r.l. | Naujas būdas, skirtas vandenyje tirpaus forskolino paruošimui |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3949085A (en) * | 1970-05-27 | 1976-04-06 | Chinoin Gyogyszer-Es Vegyeszeti Termakek Gyara Rt | Anabolic-weight-gain promoting compositions containing isoflavone derivatives and method using same |
| JPS5920230A (ja) * | 1982-07-19 | 1984-02-01 | チバ−ガイギ−・アクチエンゲゼルシヤフト | ピルプロフエン含有薬剤 |
| HU194858B (en) * | 1982-12-03 | 1988-03-28 | Chinoin Gyogyszer Es Vegyeszet | Process for producing dibenzo/b,d/pirane derivatives and pharmaceutical compositions containing them |
| DE3485000D1 (de) * | 1983-06-28 | 1991-10-10 | Takeda Chemical Industries Ltd | Gemahlene mischung. |
-
1985
- 1985-09-10 HU HU853415A patent/HU199444B/hu not_active IP Right Cessation
-
1986
- 1986-09-09 UA UA4028162A patent/UA19813A/uk unknown
- 1986-09-09 DE DE8686112466T patent/DE3688114D1/de not_active Expired - Fee Related
- 1986-09-09 JP JP61210819A patent/JPH0688993B2/ja not_active Expired - Lifetime
- 1986-09-09 EP EP19860112466 patent/EP0214647B1/de not_active Expired - Lifetime
- 1986-09-09 CA CA000517755A patent/CA1288424C/en not_active Expired - Lifetime
- 1986-09-09 CN CN86106889A patent/CN1006889B/zh not_active Expired
- 1986-09-09 DD DD86294265A patent/DD254939A5/de not_active IP Right Cessation
- 1986-09-09 AT AT86112466T patent/ATE87319T1/de not_active IP Right Cessation
- 1986-09-09 SU SU864028162A patent/SU1757472A3/ru active
- 1986-09-10 FI FI863652A patent/FI86958C/fi not_active IP Right Cessation
- 1986-09-10 PL PL1986261349A patent/PL261349A1/xx unknown
- 1986-09-10 CS CS866535A patent/CS653586A3/cs unknown
- 1986-09-10 KR KR1019860007655A patent/KR900000542B1/ko not_active IP Right Cessation
- 1986-09-10 US US06/905,837 patent/US4826963A/en not_active Expired - Fee Related
-
1987
- 1987-01-16 RU SU874028810A patent/RU2022970C1/ru active
-
1989
- 1989-11-27 US US07/442,490 patent/US5043326A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| FI86958C (fi) | 1992-11-10 |
| CS276944B6 (en) | 1992-10-14 |
| KR870002842A (ko) | 1987-04-13 |
| EP0214647A3 (en) | 1987-09-30 |
| FI863652A (fi) | 1987-03-11 |
| RU2022970C1 (ru) | 1994-11-15 |
| EP0214647B1 (de) | 1993-03-24 |
| JPS62103077A (ja) | 1987-05-13 |
| FI863652A0 (fi) | 1986-09-10 |
| JPH0688993B2 (ja) | 1994-11-09 |
| US5043326A (en) | 1991-08-27 |
| ATE87319T1 (de) | 1993-04-15 |
| US4826963A (en) | 1989-05-02 |
| PL261349A1 (en) | 1987-06-29 |
| HU199444B (en) | 1990-02-28 |
| UA19813A (uk) | 1997-12-25 |
| HUT41759A (en) | 1987-05-28 |
| CA1288424C (en) | 1991-09-03 |
| EP0214647A2 (de) | 1987-03-18 |
| KR900000542B1 (ko) | 1990-01-31 |
| FI86958B (fi) | 1992-07-31 |
| CN86106889A (zh) | 1987-07-15 |
| CS653586A3 (en) | 1992-10-14 |
| SU1757472A3 (ru) | 1992-08-23 |
| DE3688114D1 (de) | 1993-04-29 |
| CN1006889B (zh) | 1990-02-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DD254939A5 (de) | Verfahren zur herstellung von 7-isoproxy-isoflavon mit cyclodextrinen | |
| DE69331900T3 (de) | Cyclodextrinderivate mit erhöhter wasserlösichkeit und deren verwendung | |
| EP0149197B2 (de) | Pharmazeutische Präparate von in Wasser schwerlöslichen oder instabilen Arzneistoffen und Verfahren zu ihrer Herstellung | |
| DE69113713T2 (de) | Verfahren zur Herstellung von Komplexen aus mehrfachungesättigten Fettsäuren mit langer Kette und Cyclodextrinen und die so erhaltenen Komplexe. | |
| US4727064A (en) | Pharmaceutical preparations containing cyclodextrin derivatives | |
| DE2902297C2 (fi) | ||
| DE2845326C2 (de) | Verwendung einer spezifischen mikrodispersen, amorphen, porösen Kieselsäure zur Herstellung von Digoxin enthaltenden Tabletten mit stark beschleunigter Wirkstoff-Freisetzung | |
| DE102005017775A1 (de) | Komplexe aus Vitamin D-Verbindungen oder deren Analoga mit einem 5Z,7E,10(19)-Trien-System und methlierten Derivaten des ß-Cyclodextrins | |
| AT400674B (de) | Pharmazeutische pleuromutilin-zubereitung | |
| DE69334183T2 (de) | Von cyclodextrinen stabilisierter radiopharmazeutischer reagenzsatz | |
| WO1982004052A1 (en) | Method for the preparation of inclusion complexes derived from n-(1-phenyle-ethyle)-3,3-diphenyle-propylamine respectively from the hydrochloryde thereof and from cyclodextrine | |
| DE69730902T2 (de) | Verfahren zur Selektion eines Salzes zur Herstellung eines Inklusionskomplexes | |
| DE2948869C2 (fi) | ||
| DE69025691T2 (de) | Einschlusskomplexe mit Silybinin, ihre Herstellung und pharmazeutische Präparate, die diese enthalten | |
| DE3854387T2 (de) | Einschlusskomplex von Nicardipin oder seinem Hydrochlorid mit beta-Cyclodextrin, ein Verfahren zur Herstellung desselben und eine diesen enthaltende pharmazeutische Zubereitung mit verzögerter Wirkung. | |
| EP0490193A1 (de) | Komplexe des aktiven Enantiomers des Ibuprofens mit Cyclodextrin | |
| DE3238800A1 (de) | Mit (gamma)-cyclodextrin gebildete einschlusskomplexe von steroidverbindungen, verfahren zu ihrer herstellung und diese einschlusskomplexe enthaltende arzneimittelpraeparate | |
| DE69006259T2 (de) | Hypoallergene anästhesierende/hypnotische steroide Arzneizubereitung. | |
| DE4313408A1 (de) | Cyclodextrin-Biocid-Komplex | |
| DE60032388T2 (de) | Kristalline mischungen aus teilmethylethern des beta-cyclodextrins und verwandten verbindungen | |
| DE2719690A1 (de) | Stabilisierte prostaglandinzubereitung und verfahren zur herstellung derselben | |
| DE69634446T2 (de) | Selektive alkylierung von cyclodextrinen mit minimaler effektiver basizität | |
| DE60004768T2 (de) | Komplexe von paroxetin mit cyclodextrin oder cyclodextrin derivaten | |
| DE69119853T2 (de) | Einschlusskomplexe des n-ethoxycarbonyl-3-morpholino-sydnonimins oder seine mit cyclodextrin-derivaten gebildeten salze, herstellung dieser komplexe und pharmazeutische zusammensetzungen, die diese komplexe enthalten | |
| DE3815902A1 (de) | Einschlussverbindungen des 1-(4-(2-(5-chloro-2-methoxybenzamido)ethyl) -phenylsulfonyl)-3-cyclohexylharnstoffs mit (alpha)-,ss-,(gamma)-cyclodextrinen, jeweils diese enthaltendes pharmazeutisches praeparat und verfahren zu deren herstellung |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| ENJ | Ceased due to non-payment of renewal fee |